Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02771262 · ClinicalTrials.gov registry record
Making Sense of Dyspnea Assessment
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 148
- Enrollment target
NCT02771262: Completed study, sponsored by NYU Langone Health.
NCT02771262 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 148 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02771262 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 148 participants
- Enrollment target
Study Summary
Dyspnea, or uncomfortable labored breathing, is an important patient-reported outcome (PRO). It is the primary and most disabling symptom of chronic obstructive pulmonary disease (COPD). There is a high priority to improve dyspnea PRO assessment and predict exacerbations. Frequent exacerbations are associated with increased disability, decreased quality of life (QOL), and accelerated lung function decline. Goals: To test the relative sensitivity to change, responsiveness and predictive validity of a comprehensive dyspnea outcome computer adaptive test (CAT) that measures new anxiety and activity avoidance domains and is more efficient to administer than existing dyspnea scales. Expected Outcomes: Investigators expect to: 1. begin to transform how dyspnea is assessed; 2. improve dyspnea symptom management; 3. impact functional status; 4. improve QOL; 5. facilitate the earlier treatment and prevention of exacerbations; 6. improve COPD prognosis and survival; and 7. improve COPD healthcare utilization.
Primary Outcome
DMQ-CAT scales: Intensity, Anxiety, Activity avoidance, Self-efficacy
Interventions
- OTHER Pulmonary Rehabilitation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2014-10 |
| Est. Completion | 2020-02-01 |
What the finished NCT02771262 record still lists
NCT02771262 is an observational study that tracks outcomes without assigning an intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Pulmonary Rehabilitation is the first listed.
NCT02771262 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02771262 about?
NCT02771262 is a clinical study titled "Making Sense of Dyspnea Assessment". Dyspnea, or uncomfortable labored breathing, is an important patient-reported outcome (PRO). It is the primary and most disabling symptom of chronic obstructive pulmonary disease (COPD). There is a high priority to improve dyspnea PRO assessment and predict exacerbations. Frequent exacerbations are ...
What is the current status of trial NCT02771262?
This trial is currently completed. The enrollment target is 148 participants. The study started on 2014-10. Estimated completion is 2020-02-01.
What interventions are being tested in trial NCT02771262?
The interventions under investigation include: Pulmonary Rehabilitation (OTHER).
Who is sponsoring clinical trial NCT02771262?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00739362 · 148 participants · Phase 2
Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment
- NCT03161223 · 148 participants · Phase 1
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma
- NCT03858231 · 148 participants · Phase 4
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
- NCT04486352 · 148 participants · Phase 1
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia